JPWO2022053642A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022053642A5
JPWO2022053642A5 JP2023514770A JP2023514770A JPWO2022053642A5 JP WO2022053642 A5 JPWO2022053642 A5 JP WO2022053642A5 JP 2023514770 A JP2023514770 A JP 2023514770A JP 2023514770 A JP2023514770 A JP 2023514770A JP WO2022053642 A5 JPWO2022053642 A5 JP WO2022053642A5
Authority
JP
Japan
Prior art keywords
aav
protein
aavlp
amino acids
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023514770A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023540960A5 (https=
JP2023540960A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/074987 external-priority patent/WO2022053642A1/en
Publication of JP2023540960A publication Critical patent/JP2023540960A/ja
Publication of JP2023540960A5 publication Critical patent/JP2023540960A5/ja
Publication of JPWO2022053642A5 publication Critical patent/JPWO2022053642A5/ja
Pending legal-status Critical Current

Links

JP2023514770A 2020-09-10 2021-09-10 操作されたａａｖベクター Pending JP2023540960A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20195554.9 2020-09-10
EP20195554 2020-09-10
PCT/EP2021/074987 WO2022053642A1 (en) 2020-09-10 2021-09-10 Engineered aav vectors

Publications (3)

Publication Number Publication Date
JP2023540960A JP2023540960A (ja) 2023-09-27
JP2023540960A5 JP2023540960A5 (https=) 2024-09-19
JPWO2022053642A5 true JPWO2022053642A5 (https=) 2024-09-19

Family

ID=72744535

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023514770A Pending JP2023540960A (ja) 2020-09-10 2021-09-10 操作されたａａｖベクター

Country Status (7)

Country Link
US (1) US20230365942A1 (https=)
EP (1) EP4211232A1 (https=)
JP (1) JP2023540960A (https=)
CN (1) CN116323641A (https=)
AU (1) AU2021339003A1 (https=)
CA (1) CA3188763A1 (https=)
WO (1) WO2022053642A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4353737A1 (en) * 2022-10-10 2024-04-17 Universitätsklinikum Hamburg-Eppendorf Fusion proteins comprising a cell surface marker specific vhh
CN119552829A (zh) * 2023-09-01 2025-03-04 北京昌平实验室 靶向性基因编辑酶工程化的腺相关病毒及其药物组合物
AU2024342922A1 (en) 2023-09-15 2026-04-23 Othair Prothena Limited Cell penetrating agents and uses thereof
AU2024342899A1 (en) 2023-09-15 2026-04-23 Prothena Platform Technologies Limited Methods, compositions, and kits including cell-penetrating agents
WO2026052740A1 (en) * 2024-09-04 2026-03-12 Rockberg Johan Sven Erik Modular platform for gene therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
AU7522498A (en) 1997-04-08 1998-10-30 Tuchenhagen Gmbh Method and device for accelerated fermentation in cylindro-conical fermentation tanks in beer production
NZ532635A (en) 2001-11-13 2007-05-31 Univ Pennsylvania A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
EP2012122A1 (en) * 2007-07-06 2009-01-07 Medigene AG Mutated parvovirus structural proteins as vaccines
WO2012031760A1 (en) * 2010-09-08 2012-03-15 Medigene Ag Parvovirus mutated structural proteins comprising cross - protective b - cell epitopes of a hpv l2 protein as well as products and methods relating thereto
WO2016054554A1 (en) 2014-10-03 2016-04-07 University Of Massachusetts Heterologous targeting peptide grafted aavs
EP3527223A1 (en) * 2018-02-16 2019-08-21 2A Pharma AB Mutated parvovirus structural protein
EP3564263A1 (en) * 2018-05-03 2019-11-06 Universitätsklinikum Hamburg-Eppendorf Fusion proteins comprising a cell surface marker specific vhh
CN111375055B (zh) * 2020-02-20 2021-09-03 陈宛莎 一种2019-nCoV亚单位疫苗组合物及其免疫方法
CN111411118A (zh) * 2020-03-31 2020-07-14 鲲羽生物科技(江门)有限公司 抗病原高免卵黄抗体及基于aav载体疫苗制备的方法和制剂
CN111560354B (zh) * 2020-05-22 2022-07-19 中国人民解放军总医院第五医学中心 重组新型冠状病毒及其制备方法和应用

Similar Documents

Publication Publication Date Title
US12534717B2 (en) AAV capsid proteins for nucleic acid transfer
JP4842471B2 (ja) 修飾された抗原性を有するアデノ随伴ウイルスの構造タンパク質と、その製造及び使用
US7220577B2 (en) Modified AAV
JP5136766B2 (ja) キメラベクター
JP4573437B2 (ja) アデノ随伴ウイルス血清型１核酸配列、ベクターおよび同一物を含有する宿主細胞
US6962815B2 (en) AAV2 vectors and methods
AU2008202032B2 (en) A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism
JP7524166B2 (ja) 脳に指向性を有するａａｖ変異体
JP2011067212A (ja) ハイブリッドウイルス粒子とその製造方法
HU230406B1 (hu) Eljárás adeno-asszociált vírus(AAV)szekvenciák detektálására és/vagy azonosítására és az azzal azonosított új szekvenciák izolálására
JP2024050766A (ja) 改変ウイルスカプシド
KR102612148B1 (ko) 재조합 인간 II형 미토콘드리아 다이네인-유사 GTPase의 유전자 서열 및 이의 용도
US20230365942A1 (en) Engineered aav vectors
KR20240000542A (ko) 근이영양증의 유전자 요법을 위한 AAVrh74 벡터
CN111876432A (zh) 一组肝靶向新型腺相关病毒的获得及其应用
KR20250102136A (ko) 중추 신경계에서의 유전자 발현을 위한 핵산 조절 요소 및 사용 방법
JP2025527658A (ja) 組換えアデノ随伴ウイルス及びその使用
CN116790615A (zh) 一种用于过敏性疾病的基因治疗载体核酸构建体及其使用方法
JPWO2022053642A5 (https=)
EP4410988A1 (en) An aav2-vector variant for targeted transfer of genes
RU2809389C2 (ru) Мутант aav, обладающий способностью нацеливаться на головной мозг
Qian Bioengineering of Adeno-Associated Virus Serotype 5 for Increased Liver Transduction and Retention of Low Humoral Seroreactivity
WO2025057943A1 (ja) 内耳に感染性を有するａａｖ変異体
CN121914279A (zh) 用于治疗小细胞肺癌的重组aav及其制备方法
HK40069854A (en) Aav mutant having brain-targeting property